| lung development | GO:0030324 | 164 | 0.583 | |
| t cell differentiation | GO:0030217 | 174 | 0.566 | |
| stem cell fate specification | GO:0048866 | 3 | 0.434 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.403 | |
| respiratory tube development | GO:0030323 | 167 | 0.386 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.319 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.291 | |
| chromatin modification | GO:0016568 | 187 | 0.289 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.282 | |
| mesonephros development | GO:0001823 | 97 | 0.273 | |
| respiratory system development | GO:0060541 | 190 | 0.264 | |
| regionalization | GO:0003002 | 337 | 0.262 | |
| male gamete generation | GO:0048232 | 285 | 0.257 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.245 | |
| gene silencing | GO:0016458 | 38 | 0.244 | |
| lung cell differentiation | GO:0060479 | 30 | 0.241 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.241 | |
| histone modification | GO:0016570 | 159 | 0.236 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.235 | |
| stem cell maintenance | GO:0019827 | 130 | 0.225 | |
| spermatogenesis | GO:0007283 | 284 | 0.225 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.222 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.218 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.218 | |
| skeletal system development | GO:0001501 | 356 | 0.217 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.215 | |
| digestive system development | GO:0055123 | 200 | 0.214 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.213 | |
| muscle tissue development | GO:0060537 | 308 | 0.211 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.207 | |
| cell fate determination involved in pattern specification | GO:0060582 | 1 | 0.201 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.197 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.194 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.191 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.188 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.187 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.184 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.177 | |
| regulation of histone modification | GO:0031056 | 56 | 0.176 | |
| t cell activation | GO:0042110 | 289 | 0.167 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.167 | |
| striated muscle cell development | GO:0055002 | 125 | 0.164 | |
| endocardial cell differentiation | GO:0060956 | 4 | 0.164 | |
| negative regulation of glial cell proliferation | GO:0060253 | 4 | 0.161 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.161 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.158 | |
| intra golgi vesicle mediated transport | GO:0006891 | 1 | 0.156 | |
| tube formation | GO:0035148 | 140 | 0.156 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.155 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.154 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.154 | |
| regulation of schwann cell proliferation | GO:0010624 | 2 | 0.152 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.148 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.146 | |
| lung epithelium development | GO:0060428 | 37 | 0.145 | |
| kidney development | GO:0001822 | 213 | 0.144 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.140 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.136 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.135 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.133 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.131 | |
| gland development | GO:0048732 | 330 | 0.129 | |
| hindbrain development | GO:0030902 | 128 | 0.129 | |
| clara cell differentiation | GO:0060486 | 4 | 0.125 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.124 | |
| negative regulation of chromosome organization | GO:2001251 | 30 | 0.119 | |
| developmental maturation | GO:0021700 | 193 | 0.117 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.117 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.116 | |
| compartment pattern specification | GO:0007386 | 4 | 0.115 | |
| lung alveolus development | GO:0048286 | 45 | 0.114 | |
| forebrain development | GO:0030900 | 302 | 0.113 | |
| ureteric bud development | GO:0001657 | 94 | 0.112 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.111 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.109 | |
| mesenchymal cell proliferation | GO:0010463 | 44 | 0.109 | |
| myotube differentiation | GO:0014902 | 105 | 0.106 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.104 | |
| dna metabolic process | GO:0006259 | 303 | 0.103 | |
| nephron tubule development | GO:0072080 | 84 | 0.102 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.100 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.100 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.099 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.097 | |
| renal tubule development | GO:0061326 | 87 | 0.097 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.097 | |
| histone acetylation | GO:0016573 | 41 | 0.093 | |
| primary neural tube formation | GO:0014020 | 95 | 0.091 | |
| digestive tract development | GO:0048565 | 190 | 0.090 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.090 | |
| foregut morphogenesis | GO:0007440 | 12 | 0.090 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.089 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.089 | |
| epithelial tube formation | GO:0072175 | 130 | 0.088 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.088 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.087 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.086 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.086 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.085 | |
| neural tube development | GO:0021915 | 160 | 0.085 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 35 | 0.085 | |
| muscle cell development | GO:0055001 | 133 | 0.084 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.084 | |
| neuroblast fate commitment | GO:0014017 | 1 | 0.083 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.083 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.083 | |
| neuroblast fate determination | GO:0007400 | 1 | 0.082 | |
| glial cell development | GO:0021782 | 54 | 0.082 | |
| regulation of cell motility | GO:2000145 | 236 | 0.081 | |
| positive regulation of cell proliferation involved in heart valve morphogenesis | GO:0003251 | 1 | 0.081 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.080 | |
| regulation of protein deacetylation | GO:0090311 | 17 | 0.080 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.080 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.079 | |
| limb morphogenesis | GO:0035108 | 149 | 0.078 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.078 | |
| formation of anatomical boundary | GO:0048859 | 6 | 0.077 | |
| pigment accumulation | GO:0043476 | 1 | 0.077 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.077 | |
| glial cell differentiation | GO:0010001 | 131 | 0.075 | |
| sensory organ boundary specification | GO:0008052 | 1 | 0.075 | |
| connective tissue development | GO:0061448 | 179 | 0.075 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.075 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.074 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.073 | |
| ossification | GO:0001503 | 216 | 0.073 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.073 | |
| activation of immune response | GO:0002253 | 138 | 0.073 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.071 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.070 | |
| neural tube closure | GO:0001843 | 90 | 0.070 | |
| regulation of cell activation | GO:0050865 | 289 | 0.070 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.069 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.069 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.069 | |
| regulation of cell cycle g2 m phase transition | GO:1902749 | 10 | 0.069 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.068 | |
| stem cell proliferation | GO:0072089 | 117 | 0.067 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.067 | |
| compound eye development | GO:0048749 | 1 | 0.067 | |
| regulation of system process | GO:0044057 | 200 | 0.066 | |
| regulation of tolerance induction dependent upon immune response | GO:0002652 | 1 | 0.066 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.066 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.064 | |
| regulation of fibroblast proliferation | GO:0048145 | 34 | 0.064 | |
| striated muscle cell proliferation | GO:0014855 | 39 | 0.064 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.064 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.063 | |
| muscle fiber development | GO:0048747 | 76 | 0.063 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.062 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.062 | |
| endocrine system development | GO:0035270 | 98 | 0.062 | |
| cerebellar granule cell precursor tangential migration | GO:0021935 | 1 | 0.061 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.061 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.061 | |
| amine metabolic process | GO:0009308 | 45 | 0.060 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.060 | |
| chromatin organization | GO:0006325 | 206 | 0.059 | |
| neural tube formation | GO:0001841 | 108 | 0.059 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.058 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.058 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.058 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.058 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.057 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.057 | |
| b cell differentiation | GO:0030183 | 78 | 0.056 | |
| cardiac right ventricle formation | GO:0003219 | 3 | 0.056 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.056 | |
| negative regulation of growth | GO:0045926 | 99 | 0.056 | |
| gene silencing by rna | GO:0031047 | 19 | 0.055 | |
| glomerular mesangial cell differentiation | GO:0072008 | 3 | 0.055 | |
| cartilage development | GO:0051216 | 140 | 0.055 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.054 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.054 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.054 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.053 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.053 | |
| cerebellum development | GO:0021549 | 77 | 0.053 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.053 | |
| cell fate commitment | GO:0045165 | 210 | 0.053 | |
| arterial endothelial cell differentiation | GO:0060842 | 5 | 0.052 | |
| negative regulation of osteoblast proliferation | GO:0033689 | 4 | 0.052 | |
| regulation of mesenchymal cell proliferation involved in lung development | GO:2000790 | 2 | 0.052 | |
| striated muscle contraction | GO:0006941 | 45 | 0.052 | |
| urogenital system development | GO:0001655 | 261 | 0.051 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.051 | |
| blastocyst development | GO:0001824 | 80 | 0.051 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.051 | |
| positive regulation of chromatin binding | GO:0035563 | 3 | 0.050 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.050 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.049 | |
| spinal cord development | GO:0021510 | 81 | 0.049 | |
| atrioventricular node development | GO:0003162 | 3 | 0.049 | |
| pro t cell differentiation | GO:0002572 | 3 | 0.048 | |
| response to radiation | GO:0009314 | 165 | 0.048 | |
| appendage development | GO:0048736 | 166 | 0.048 | |
| blood circulation | GO:0008015 | 195 | 0.048 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.047 | |
| formation of radial glial scaffolds | GO:0021943 | 4 | 0.047 | |
| immature b cell differentiation | GO:0002327 | 10 | 0.047 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.047 | |
| cell proliferation in forebrain | GO:0021846 | 30 | 0.047 | |
| mesangial cell differentiation | GO:0072007 | 4 | 0.046 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.046 | |
| germ cell development | GO:0007281 | 185 | 0.046 | |
| secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | GO:0060528 | 4 | 0.046 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.046 | |
| nephrogenic mesenchyme morphogenesis | GO:0072134 | 2 | 0.046 | |
| face morphogenesis | GO:0060325 | 29 | 0.046 | |
| negative regulation of leukocyte proliferation | GO:0070664 | 46 | 0.046 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.046 | |
| axonogenesis | GO:0007409 | 274 | 0.046 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.046 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.045 | |
| regulation of mesenchymal cell proliferation | GO:0010464 | 37 | 0.045 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.045 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.045 | |
| negative regulation of mesenchymal cell proliferation involved in lung development | GO:2000791 | 2 | 0.044 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.044 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.044 | |
| nuclear transport | GO:0051169 | 139 | 0.044 | |
| cell proliferation involved in heart valve morphogenesis | GO:0003249 | 1 | 0.044 | |
| chemotaxis | GO:0006935 | 247 | 0.044 | |
| intracellular protein transport | GO:0006886 | 204 | 0.043 | |
| gene silencing by mirna | GO:0035195 | 10 | 0.043 | |
| reproductive behavior | GO:0019098 | 32 | 0.043 | |
| oligodendrocyte development | GO:0014003 | 20 | 0.043 | |
| protein catabolic process | GO:0030163 | 221 | 0.042 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.042 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 3 | 0.042 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.042 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.042 | |
| regulation of histone deacetylation | GO:0031063 | 12 | 0.041 | |
| head morphogenesis | GO:0060323 | 34 | 0.041 | |
| limb development | GO:0060173 | 166 | 0.041 | |
| metanephros development | GO:0001656 | 79 | 0.041 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.041 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.041 | |
| tube closure | GO:0060606 | 91 | 0.040 | |
| kidney epithelium development | GO:0072073 | 121 | 0.040 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.040 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.040 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.040 | |
| thymus development | GO:0048538 | 41 | 0.040 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.039 | |
| inflammatory response | GO:0006954 | 244 | 0.039 | |
| muscle contraction | GO:0006936 | 101 | 0.039 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.039 | |
| negative regulation of histone modification | GO:0031057 | 18 | 0.039 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.039 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.039 | |
| translation | GO:0006412 | 93 | 0.039 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.039 | |
| positive regulation of immature t cell proliferation | GO:0033091 | 4 | 0.038 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.038 | |
| cardiac endothelial cell differentiation | GO:0003348 | 4 | 0.038 | |
| calcium mediated signaling using intracellular calcium source | GO:0035584 | 3 | 0.038 | |
| neuronal action potential | GO:0019228 | 54 | 0.038 | |
| midgut development | GO:0007494 | 4 | 0.038 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.037 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.037 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.037 | |
| regulation of cardiac cell fate specification | GO:2000043 | 1 | 0.036 | |
| positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus | GO:1901522 | 7 | 0.036 | |
| liver development | GO:0001889 | 66 | 0.036 | |
| nephron epithelium development | GO:0072009 | 92 | 0.036 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.036 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.036 | |
| epithelial cell development | GO:0002064 | 159 | 0.035 | |
| multi organism reproductive behavior | GO:0044705 | 29 | 0.035 | |
| fat cell differentiation | GO:0045444 | 160 | 0.035 | |
| cell migration involved in endocardial cushion formation | GO:0003273 | 3 | 0.035 | |
| nephron development | GO:0072006 | 109 | 0.035 | |
| protein ubiquitination | GO:0016567 | 171 | 0.035 | |
| cell fate determination | GO:0001709 | 32 | 0.035 | |
| protein acylation | GO:0043543 | 64 | 0.035 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.035 | |
| protein deacetylation | GO:0006476 | 32 | 0.035 | |
| somite development | GO:0061053 | 81 | 0.035 | |
| rhythmic process | GO:0048511 | 174 | 0.035 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.035 | |
| negative regulation of calcium ion dependent exocytosis | GO:0045955 | 3 | 0.035 | |
| organ growth | GO:0035265 | 117 | 0.034 | |
| regulation of ossification | GO:0030278 | 112 | 0.034 | |
| cytokine biosynthetic process | GO:0042089 | 68 | 0.034 | |
| lung morphogenesis | GO:0060425 | 50 | 0.034 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.034 | |
| negative regulation of chromatin modification | GO:1903309 | 19 | 0.034 | |
| rhombomere morphogenesis | GO:0021593 | 2 | 0.034 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.034 | |
| bone development | GO:0060348 | 120 | 0.033 | |
| renal system development | GO:0072001 | 225 | 0.033 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.033 | |
| lipid localization | GO:0010876 | 126 | 0.033 | |
| cellular response to lipid | GO:0071396 | 145 | 0.033 | |
| circulatory system process | GO:0003013 | 197 | 0.033 | |
| cell proliferation involved in heart valve development | GO:2000793 | 2 | 0.033 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.033 | |
| regulation of histone acetylation | GO:0035065 | 19 | 0.033 | |
| stem cell differentiation | GO:0048863 | 268 | 0.033 | |
| positive regulation of lymphocyte anergy | GO:0002913 | 4 | 0.033 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.033 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.033 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.033 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.033 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.032 | |
| heart process | GO:0003015 | 94 | 0.032 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 35 | 0.032 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.032 | |
| formation of organ boundary | GO:0010160 | 1 | 0.031 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.031 | |
| heart contraction | GO:0060047 | 93 | 0.031 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.031 | |
| cardiac muscle cell proliferation | GO:0060038 | 31 | 0.031 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.031 | |
| regulation of gliogenesis | GO:0014013 | 50 | 0.031 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.030 | |
| peripheral nervous system neuron axonogenesis | GO:0048936 | 3 | 0.030 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.030 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.030 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.030 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.030 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.030 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.030 | |
| lung epithelial cell differentiation | GO:0060487 | 29 | 0.030 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.030 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.030 | |
| embryonic digestive tract development | GO:0048566 | 27 | 0.030 | |
| protein maturation | GO:0051604 | 176 | 0.030 | |
| palate development | GO:0060021 | 76 | 0.029 | |
| fibroblast proliferation | GO:0048144 | 35 | 0.029 | |
| regulation of defense response | GO:0031347 | 233 | 0.029 | |
| heart growth | GO:0060419 | 45 | 0.029 | |
| v d j recombination | GO:0033151 | 14 | 0.029 | |
| insulin secretion | GO:0030073 | 89 | 0.029 | |
| circadian rhythm | GO:0007623 | 114 | 0.029 | |
| negative regulation of interleukin 5 production | GO:0032714 | 4 | 0.029 | |
| regulation of interleukin 2 secretion | GO:1900040 | 6 | 0.029 | |
| reflex | GO:0060004 | 22 | 0.028 | |
| metanephric mesenchyme morphogenesis | GO:0072133 | 4 | 0.028 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.028 | |
| regulation of lymphocyte anergy | GO:0002911 | 4 | 0.028 | |
| regulation of glial cell differentiation | GO:0045685 | 41 | 0.028 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.028 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.028 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.028 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.028 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.028 | |
| negative regulation of osteoblast differentiation | GO:0045668 | 30 | 0.028 | |
| myelination | GO:0042552 | 74 | 0.027 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.027 | |
| protein localization to organelle | GO:0033365 | 185 | 0.027 | |
| response to growth factor | GO:0070848 | 198 | 0.027 | |
| rhombomere formation | GO:0021594 | 1 | 0.027 | |
| positive regulation of dendrite development | GO:1900006 | 21 | 0.027 | |
| mesodermal cell fate commitment | GO:0001710 | 17 | 0.027 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.027 | |
| maintenance of chromatin silencing | GO:0006344 | 2 | 0.027 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.027 | |
| b cell activation | GO:0042113 | 161 | 0.027 | |
| male sex determination | GO:0030238 | 14 | 0.027 | |
| face development | GO:0060324 | 38 | 0.027 | |
| cell cycle arrest | GO:0007050 | 37 | 0.026 | |
| regulation of neuron death | GO:1901214 | 134 | 0.026 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.026 | |
| cell maturation | GO:0048469 | 127 | 0.026 | |
| cd4 positive cd25 positive alpha beta regulatory t cell differentiation | GO:0002361 | 4 | 0.026 | |
| rna interference | GO:0016246 | 2 | 0.026 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.026 | |
| camera type eye development | GO:0043010 | 266 | 0.026 | |
| amide transport | GO:0042886 | 138 | 0.026 | |
| protein import into nucleus | GO:0006606 | 95 | 0.025 | |
| negative regulation of lymphocyte proliferation | GO:0050672 | 45 | 0.025 | |
| transforming growth factor beta1 production | GO:0032905 | 3 | 0.025 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.025 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.025 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.025 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.025 | |
| pharynx development | GO:0060465 | 1 | 0.025 | |
| regulation of cell migration | GO:0030334 | 219 | 0.025 | |
| epithelial to mesenchymal transition involved in endocardial cushion formation | GO:0003198 | 10 | 0.025 | |
| gonad development | GO:0008406 | 141 | 0.025 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.025 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.025 | |
| regulation of transcription from rna polymerase ii promoter in response to hypoxia | GO:0061418 | 2 | 0.025 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.024 | |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 34 | 0.024 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.024 | |
| histone deacetylation | GO:0016575 | 26 | 0.024 | |
| bone morphogenesis | GO:0060349 | 78 | 0.024 | |
| astrocyte differentiation | GO:0048708 | 43 | 0.024 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.024 | |
| positive regulation of stem cell differentiation | GO:2000738 | 23 | 0.024 | |
| peptide secretion | GO:0002790 | 114 | 0.024 | |
| schwann cell proliferation | GO:0014010 | 2 | 0.024 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.024 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.024 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.024 | |
| placenta development | GO:0001890 | 140 | 0.024 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.024 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.024 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.024 | |
| wound healing | GO:0042060 | 157 | 0.024 | |
| bone mineralization | GO:0030282 | 54 | 0.024 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.023 | |
| protein polyubiquitination | GO:0000209 | 33 | 0.023 | |
| cardiac muscle tissue growth | GO:0055017 | 37 | 0.023 | |
| protein dna complex disassembly | GO:0032986 | 1 | 0.023 | |
| definitive erythrocyte differentiation | GO:0060318 | 7 | 0.023 | |
| protein processing | GO:0016485 | 163 | 0.023 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.023 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.023 | |
| regulation of protein transport | GO:0051223 | 163 | 0.023 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.023 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.023 | |
| neuron projection guidance | GO:0097485 | 141 | 0.023 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.023 | |
| regulation of transcription from rna polymerase ii promoter in response to stress | GO:0043618 | 8 | 0.023 | |
| humoral immune response | GO:0006959 | 57 | 0.023 | |
| regulation of glial cell proliferation | GO:0060251 | 8 | 0.022 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.022 | |
| neuron projection extension | GO:1990138 | 64 | 0.022 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.022 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.022 | |
| endothelium development | GO:0003158 | 45 | 0.022 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.022 | |
| regulation of t cell anergy | GO:0002667 | 4 | 0.022 | |
| glial cell fate commitment | GO:0021781 | 14 | 0.022 | |
| protein deacylation | GO:0035601 | 36 | 0.021 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.021 | |
| prostate glandular acinus development | GO:0060525 | 12 | 0.021 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.021 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.021 | |
| cellular response to acidic ph | GO:0071468 | 4 | 0.021 | |
| positive regulation of binding | GO:0051099 | 49 | 0.021 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.021 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.021 | |
| phosphatidylinositol 3 kinase signaling | GO:0014065 | 36 | 0.021 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.021 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.021 | |
| positive regulation of regulatory t cell differentiation | GO:0045591 | 4 | 0.021 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.021 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.021 | |
| negative regulation of photoreceptor cell differentiation | GO:0046533 | 4 | 0.021 | |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 35 | 0.021 | |
| regulation of proteasomal protein catabolic process | GO:0061136 | 46 | 0.021 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.021 | |
| t cell anergy | GO:0002870 | 4 | 0.021 | |
| sensory perception | GO:0007600 | 245 | 0.021 | |
| histone h4 acetylation | GO:0043967 | 10 | 0.021 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.021 | |
| hormone secretion | GO:0046879 | 128 | 0.021 | |
| negative regulation of muscle cell differentiation | GO:0051148 | 33 | 0.021 | |
| positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902043 | 13 | 0.021 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.021 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.020 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.020 | |
| response to drug | GO:0042493 | 75 | 0.020 | |
| positive regulation of mitotic cell cycle phase transition | GO:1901992 | 17 | 0.020 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.020 | |
| negative regulation of interleukin 2 production | GO:0032703 | 8 | 0.020 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.020 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.020 | |
| hindlimb morphogenesis | GO:0035137 | 42 | 0.020 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.020 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.020 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.020 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.020 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.020 | |
| regulation of organ growth | GO:0046620 | 61 | 0.020 | |
| cell cell adhesion via plasma membrane adhesion molecules | GO:0098742 | 40 | 0.020 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.020 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.020 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.020 | |
| endoderm development | GO:0007492 | 45 | 0.020 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.020 | |
| neural tube patterning | GO:0021532 | 43 | 0.020 | |
| interleukin 2 production | GO:0032623 | 33 | 0.019 | |
| regulation of transcription during meiosis | GO:0051037 | 1 | 0.019 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.019 | |
| blastocyst formation | GO:0001825 | 33 | 0.019 | |
| regulation of respiratory system process | GO:0044065 | 13 | 0.019 | |
| regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter | GO:0072364 | 7 | 0.019 | |
| prostate gland epithelium morphogenesis | GO:0060740 | 31 | 0.019 | |
| protein secretion | GO:0009306 | 111 | 0.019 | |
| regulation of protein processing | GO:0070613 | 96 | 0.019 | |
| glucose homeostasis | GO:0042593 | 128 | 0.019 | |
| epithelial cell proliferation involved in prostate gland development | GO:0060767 | 11 | 0.019 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.019 | |
| membrane depolarization | GO:0051899 | 64 | 0.019 | |
| protein import | GO:0017038 | 101 | 0.019 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.019 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.019 | |
| response to uv | GO:0009411 | 44 | 0.019 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.019 | |
| immune effector process | GO:0002252 | 321 | 0.019 | |
